How a brain receptor helps stem cells respond after stroke

LRP1 as a novel regulator of CXCR4 in adult neural stem cells and post-stroke response

NIH-funded research University of Texas Hlth Science Center · NIH-11123171

This work looks at whether changing a receptor called LRP1 can help adult brain stem cells find and repair damaged areas after an ischemic stroke to improve recovery.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of Texas Hlth Science Center NIH-funded
Lab location1 site (San Antonio, United States)
Project IDNIH-11123171 on NIH RePORTER

What this research studies

From a patient point of view, researchers are studying how a protein called LRP1 controls a signaling receptor (CXCR4) that guides adult neural stem cells to damaged brain tissue after a stroke. In the lab they remove LRP1 in adult stem cells and use an animal stroke model to watch how those cells migrate, how big the brain lesion becomes, and how function recovers. The team measures changes in cell signaling, location, and tissue repair to learn why LRP1 loss alters stem cell behavior. Their goal is to identify targets that could help future therapies direct stem cells to damaged areas and boost repair after ischemic stroke.

Who could benefit from this research

Good fit: Adults who have experienced an ischemic (blood-flow) stroke and are interested in future therapies to improve brain repair and recovery would be the likely candidates for related clinical work.

Not a fit: People with non-ischemic brain injury, those whose stroke damage is very old and stable, or patients unable to receive stem-cell–based treatments would be less likely to benefit from this specific line of research.

Why it matters

Potential benefit: If successful, this could point to ways to boost stem cell–based repair after stroke and reduce long-term disability.

How similar studies have performed: Stem cell approaches and CXCR4-guided migration have helped recovery in animal stroke models, but targeting LRP1 as a regulator of CXCR4 is a novel direction.

Where this research is happening

San Antonio, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions Acquired brain injury
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.